Business · 23/05/2000Updated: 10/17/2026 · 1 min read
FDA's Psychopharmacological Drugs Advisory Committee to Hold Meeting on Upcoming Regulations
Summary
The FDA's Psychopharmacological Drugs Advisory Committee will convene to discuss and provide recommendations on upcoming regulations related to psychopharmacological drugs, following a recent request from the agency to gather expert input on the matter.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →